News tagged with anthracycline

African-American breast cancer survivors face higher risk of heart failure

African-American women who survive breast cancer are more likely to develop heart failure than other women who have beaten the disease, according to research being presented at the American College of Cardiology's 62nd Annual ...

Cardiology Mar 07, 2013 | not rated yet | 0

Study compares standard against newer treatment in women whose breast cancer has spread

Results from a phase III clinical trial comparing a newer chemotherapy agent called eribulin mesylate with capecitabine, a standard drug used for chemotherapy today in women with previously treated metastatic breast cancer, ...

Cancer Dec 07, 2012 | not rated yet | 0

Prolonged dexamethasone cuts delayed nausea after chemo

(HealthDay) -- Adding dexamethasone to prochlorperazine on days two and three, following palonosetron and dexamethasone on day one, reduces delayed nausea (DN) in patients receiving chemotherapy containing ...

Cancer Aug 22, 2012 | not rated yet | 0

Childhood cancer survivors at risk for cardiac events

(HealthDay) -- Childhood cancer survivors (CCSs) treated with anthracyclines and/or cardiac irradiation have a higher risk of developing symptomatic cardiac events (CEs) in the long term, according to a study ...

Cardiology Apr 04, 2012 | not rated yet | 0

Survival increased in early stage breast cancer after treatment with herceptin and chemo

Treating women with early stage breast cancer with a combination of chemotherapy and the molecularly targeted drug Herceptin significantly increases survival in patients with a specific genetic mutation that results in very ...